0000950170-24-002701.txt : 20240108 0000950170-24-002701.hdr.sgml : 20240108 20240108080005 ACCESSION NUMBER: 0000950170-24-002701 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240105 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DelAversano Robert J CENTRAL INDEX KEY: 0001728262 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35776 FILM NUMBER: 24518378 MAIL ADDRESS: STREET 1: 217 W. MAIN STREET CITY: SOMERVILLE STATE: NJ ZIP: 08876 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acasti Pharma Inc. CENTRAL INDEX KEY: 0001444192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-649-9272 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 3 1 ownership.xml 3 X0206 3 2024-01-05 0 0001444192 Acasti Pharma Inc. ACST 0001728262 DelAversano Robert J 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 false true false false Vice President, Finance Stock Options (Right to Buy) 2.125 2033-12-19 Class A Common Shares 42000 D (1) Stock options granted on December 19, 2023 under the Acasti Pharma Inc. Stock Option Plan, which options vest in equal quarterly installments over a period of 36 months. /s/ Robert J. DelAversano 2024-01-08